Melocox

Meloxicam, the active ingredient in Melocox, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It belongs to the COX‑2 preferential inhibitor class and is marketed in the European Union. The medication is used to relieve pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adults.

GNH USA supplies Melocox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam acts on inflammatory pathways and is indicated for several musculoskeletal and rheumatic conditions.

Osteoarthritis: reduces joint pain and swelling, improving mobility. Rheumatoid arthritis: alleviates inflammatory joint symptoms and slows functional decline. Ankylosing spondylitis: diminishes spinal inflammation and associated pain. Acute pain: provides short‑term relief of moderate to severe pain from injuries or postoperative states.

Meloxicam may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: mild swelling of the lower limbs.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: sudden decrease in kidney function. - Hepatotoxicity: elevated liver enzymes or hepatitis.

Before prescribing meloxicam, clinicians should evaluate several safety considerations.

Renal function: assess baseline kidney function and monitor in patients with renal impairment. Cardiovascular risk: use cautiously in individuals with hypertension, heart failure or a history of thrombotic events. Gastrointestinal history: avoid in patients with active peptic ulcer disease or a history of serious GI bleeding. Concomitant NSAIDs or anticoagulants: increase risk of bleeding; consider alternative therapy. Pregnancy and lactation: avoid unless clearly needed; limited safety data are available. Store at room temperature: keep in the original container, protect from moisture and light.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Selective COX‑2 inhibitors (e.g., celecoxib): additive toxicity; concurrent use not recommended. - Lithium: meloxicam may raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal function, especially in dehydrated patients. - Diuretics: potential for decreased kidney perfusion. - Methotrexate: possible increase in methotrexate toxicity.